Shanghai Junshi Biosciences Co., Ltd.

Chinese biopharma developing and selling cancer, immune and other drugs

What Shanghai Junshi Biosciences does

Junshi Biosciences discovers, develops and sells prescription medicines, mostly in China. Its marketed drugs treat cancer, autoimmune diseases such as rheumatoid arthritis and psoriasis, and high blood lipids. It also has a large pipeline of antibodies, small-molecule drugs and antibody-drug conjugates in clinical trials, mainly for cancer.

How Shanghai Junshi Biosciences makes money

It makes money by selling its approved drugs, including the cancer drug TUOYI/LOQTORZI and the autoimmune drug JUNMAIKANG. It spends heavily on clinical trials to bring pipeline candidates to market.

Products & services

• TUOYI/LOQTORZI/ZYTORVI (tumors)
• JUNMAIKANG (autoimmune diseases)
• JUNSHIDA (hyperlipidemia)
• VV116/JT001 (oral nucleoside analog)
• Tifcemalimab (anti-BTLA, Phase III)
• JS107 (antibody-drug conjugate, Phase III)